Dexmedetomidine in the Treatment of Agitation Associated With Dementia (TRANQUILITY III)
Clinical trial NCT05665088 · TERMINATED
Trial details
- NCT number
- NCT05665088
- Sponsor
- BioXcel Therapeutics Inc
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-14
- Primary completion
- 2023-09-11
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.